Background
==========

Polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) are two inflammatory diseases that are thought to arise from a complex interaction between multiple genetic factors and environmental triggers. We have previously demonstrated an association between the Fc gamma receptor (FcγR) genetic locus on chromosome 1q22-23 and rheumatoid arthritis, and have now extended our study to include other inflammatory/autoimmune diseases.

Methods
=======

The *FCGR2A-131H/R*, *FCGR3A-158F/V*and *FCGR3B-NA1/NA2*functional polymorphisms and a novel *FCGR2B*3\'-UTR polymorphism were examined for association with PMR (*n*= 69) and GCA (*n*= 83) in two well-characterised clinical cohorts from Northern Spain. In view of the close molecular proximity between *FCGR2A*, *FCGR3A*, *FCGR3B*and *FCGR2B*we have examined FcγR haplotypes for association with rheumatoid arthritis. Pairwise disequilibrium coefficients (*D\'*) were initially calculated in 115 matched controls. The EHPlus program was used to estimate haplotype frequencies for patients and controls and to determine whether significant linkage disequilibrium was present. A likelihood ratio test is performed to test for differences between the haplotype frequencies in cases and controls. A permutation procedure implemented in this program enabled 1000 permutations to be performed on all haplotype associations to assess significance.

Results
=======

There was borderline linkage disequilibrium between *FCGR2A*and *FCGR3A*(*D\'*= -0.313, *P*= 0.03) with more significant disequilibrium between *FCGR3A*and *FCGR3B*(*D\'*= -0.646, *P*= 0.0001). There was a significant difference in the *FCGR2A*allele (*P*= 0.03) and genotype frequencies (*P*= 0.03) with GCA compared with controls. Specifically, there was an increase in the *FCGR2A*-131RR genotype in both the PMR (odds ratio \[OR\] = 2.15; 95% confidence interval \[CI\] = 1.0--4.7, *P*= 0.05) and GCA (OR = 2.53, 95% CI = 1.3--5.1, *P*= 0.01) populations compared with controls.

Increased homozygosity for the *FCGR2A*-*FCGR3A*131R-158F haplotype was found in 8% controls compared with 25% of PMR (OR = 4.20, 95% CI = 1.3--13.1, *P*= 0.01) and 24% GCA (OR = 4.46, 95% CI = 1.5--3.3, *P*= 0.004) individuals. Logistic regression analyses suggested that both *FCGR2A*and *FCGR3A*contributed to GCA susceptibility. In addition, homozygosity for the *FCGR3A*-*FCGR3B*158F-NA2 haplotype was found in 25% controls compared with 44% GCA subjects (OR = 2.35, 95% CI = 1.0--5.7, *P*= 0.06). Logistic regression analyses suggested that *FCGR3A*was the most important site contributing to GCA susceptibility.

A subgroup of GCA patients who had experienced visual symptoms was examined as a marker of disease severity. The most significant findings were increased homozygosity of a *FCGR2A*-*FCGR3A*131R-158F haplotype (8% controls, 16% GCA without visual manifestations and 50% GCA with visual manifestations \[OR = 12.86, 95% CI = 1.3--128.2, *P*= 0.03\]). Additionally, the *FCGR3A*-*FCGR3B*haplotype was found in 11/13 individuals who sustained visual manifestations. Homozygosity was seen in 25% controls, 27% GCA without eye involvement and 63% GCA with visual manifestations (OR = 5.83, 95% CI = 0.9--38.9, *P*= 0.08). For each haplotype logistic regression analyses suggested *FCGR3A*was the most important site.

Conclusions
===========

We have demonstrated that *FCGR2A*may contribute to the \'susceptibility\' of PMR and GCA in this Spanish population. The increased association observed with a *FCGR2A*-*FCGR3A*haplotype suggests the presence of additional genetic polymorphisms in linkage disequilibrium with this haplotype that may contribute to disease susceptibility. In addition, FcγR haplotypes may potentially define a subpopulation of individuals at greater risk of vascular occlusion. These findings may ultimately provide new insights into disease pathogenesis.
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